News from the cancer side, April 10



easter_eggHere’s your cancer news round up for the Easter weekend. Happy Easter, every one!

News from the academia

University centre, students tackling cancer in high-risk state
The Centre for Health and Human Services (CHHS) at Middle Tennessee State University is planning to set up a Tennessee Colorectal Cancer Screening Pilot Program that will give colorectal cancer screening access to low-income residents of Tennessee. The state ranks 3rd in the US in cancer mortality rates. Colorectal cancer is the 2nd leading cause of cancer deaths in the state. The CHHS will be working together with the Tennessee Comprehensive Cancer Control Coalition to find the reason why Tennessee ranks so high in cancer.

News from the stem cell researchers

Breakthrough makes lab-produced stem cells safer for humans
British and Canadian researchers may have found a way to overcome the barriers that prevent stem cells made from skin cells from being transplanted to humans safely. The development of stem cells from skin cells made headlines in 2006 as a major breakthough in stem cell research. However, its clinical application was hindered by health risks associated with the transplantation.

News from the regulators

FDA Greenlights New Drug for Advanced Kidney Cancer
The US FDA has approved everolimus (Afinitor) for the treatment of renal cell carcinoma. (advanced kidney cancer). Afinitor does not cure the cancer but delays the spread and reduces the growth of the tumors by about 5 months. Afinitor is manufactured by Novartis.

News from the statisticians

Lead Story: Hospital Admissions on the Rise for People Without Health Insurance
The U.S. Agency for Healthcare Research and Quality (AHRQ) reports that hospital admissions of people without health insurance coverage are up by a third between 1997 and 2006. AHRQ presented the numbers and the story in a podcast last Wednesday, April 9.

News from the genetic experts

New ACOG Guidelines Recommend Routine Genetic Risk Assessment
The American College of Obstetricians and Gynecologists (ACOG) and the Society of Gynecologic Oncologists (SGO) have just released new guidelines which recommend that women should be routine assessed for genetic predisposition foe break can ovarian cancer. Women who eventually undergo genetic testing and are found to carry a BRCA1 or BRCA2 gene mutation have options available to manage their increased risk of cancer. These guidelines were published in Obstetrics and Gynecology.

News from the advocacy groups

Cancer activities for April
The season has started for walking or running events at your local Susan Komen chapters. Whether you are a leisurely walker or a marathon runner, there is an event for you to participate in. Register now!

Related Posts with Thumbnails
Print Friendly

Speak Your Mind

*


*

NOTE: The contents in this blog are for informational purposes only, and should not be construed as medical advice, diagnosis, treatment or a substitute for professional care. Always seek the advice of your physician or other qualified health professional before making changes to any existing treatment or program. Some of the information presented in this blog may already be out of date.
Read previous post:
Diabetic? You can still have fun at Easter!

Being a diabetic at Easter can be very difficult. Especially if you are a little child. Sweets and goodies everywhere...

Close